Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies

NCT01499147 is registered in ClinicalTrials.gov with University of Illinois at Chicago as lead sponsor.

NCT NCT01499147
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01499147 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies
Lead sponsor
University of Illinois at Chicago
Phase
Not applicable
Overall status
Completed
Start date
February 29, 2000
Completion date
May 31, 2013
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute leukemia, acute myeloid leukemia, aplastic anemia, chronic myelogenous leukemia, hodgkin's disease, lymphocytic leukemia, malignant lymphoma, multiple myeloma, myelofibrosis, myeloproliferative disorder, polycythemia vera